How to improve metastatic pancreatic ductal adenocarcinoma patients’ selection: Between clinical trials and the real-world

Table 1 Baseline characteristics of patients treated with second-line Nal-iri at the Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy

Baseline characteristics	Patients, %
Sex
Male	71
Female	29
Age, yr
< 65	36
≥ 65	64
Location of primary tumour
Head-uncinate process	57
Body	21.5
Tail	21.5
Previous surgery
Yes	28.5
No	71.5
Number of metastatic sites
Single site	36
Multiple sites	64
Location of metastatic sites
Lymph nodes	78.5
Liver	57
Peritoneum	42.8
Lung	35.7
First-line chemotherapy regimen
Gemcitabine-nab-paclitaxel	92.8
Other	7.2